- AU$313.66m
- AU$470.22m
- AU$254.96m
- 75
- 74
- 25
- 61
Annual income statement for Monash IVF, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 145 | 184 | 192 | 214 | 255 |
| Cost of Revenue | |||||
| Gross Profit | 129 | 164 | 173 | 191 | 228 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 124 | 145 | 164 | 180 | 261 |
| Operating Profit | 21.8 | 38.7 | 28.4 | 33.1 | -5.61 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 16.1 | 36.2 | 26.2 | 29.8 | -10.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 11.8 | 25.7 | 18.5 | 22 | -5.95 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 11.7 | 25.3 | 18.4 | 21.8 | -6.53 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 11.7 | 25.3 | 18.4 | 21.8 | -6.53 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.052 | 0.059 | 0.055 | 0.065 | 0.066 |
| Dividends per Share |